Michael J. Flister

AbbVie (United States)

Papers

2

Total Citations

12

H-Index

2

About

Michael J. Flister is a leading researcher in functional genomics, with a primary focus on advancing CRISPR-based technologies for high-throughput genetic screening. His major contributions center on optimizing genomewide loss-of-function (LOF) screening platforms, particularly through the innovative use of AsCas12a and multi-guide arrays. In his most-cited work (2023, 10 citations), Flister addresses a critical bottleneck in conventional CRISPR-Cas9 libraries—namely, off-target effects and inefficient gene coverage—by engineering more precise and scalable guide RNA designs. This methodological breakthrough enables researchers to systematically interrogate gene function across diverse physiological and pathophysiological systems, from cancer biology to developmental disorders. By refining the specificity and throughput of CRISPR screens, Flister’s work empowers the discovery of novel therapeutic targets and deepens our understanding of complex genetic networks. His contributions are especially impactful for students and researchers seeking robust tools for functional genomics, as they reduce experimental noise and accelerate the identification of disease-relevant genes. Flister’s achievements underscore his role in pushing the boundaries of genome engineering, making him a pivotal figure in the evolution of CRISPR-based discovery science.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Optimization of Genomewide CRISPR Screens Using AsCas12a and Multi-Guide Arrays
10 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: AbbVie (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago